TXA2 production has been shown to be increased in human mammary carcinomas relative to that in normal breast tissues and was related to increased tumor size and metastatic potential, as well as the absence of estrogen (ER) and progesterone receptors (PR) 42. The gene discussed is PGR; the disease is breast carcinoma.